Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Flomics is a biotechnology company specializing in genomics and liquid biopsy. By integrating Next-Generation Sequencing (NGS) with machine learning, Flomics has developed a liquid biopsy test that…

Flomics is a biotechnology company specializing in genomics and liquid biopsy. By integrating Next-Generation Sequencing (NGS) with machine learning, Flomics has developed a liquid biopsy test that…
Headquarters: Barcelona, Spain
Core technology: cfRNA-based liquid biopsy using NGS + machine learning (Stratus® platform)
Founded: 2018
Team size (approx.): 23 employees
Recent funding: €1.1M seed round announced March 2024 (company release)
Early detection and biomarker discovery for cancer and complex diseases using circulating cell-free RNA and NGS-based assays.
2018
Biotechnology Research
€1.1M
Supported by Decelera Ventures, FCR, Histemi Inversiones and additional backers; company announcement
$2.3M (total across two rounds reported by Dealroom)
Aggregate total reported by Dealroom
“Backers named in company release include Decelera Ventures, FCR, Histemi Inversiones and a U.S. family office; also ran a crowdfunding campaign with Capital Cell”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,400+
New This Week
| Company |
|---|